Immunotherapy Drugs Market Size, Share, Trends, Growth 2032

Immunotherapy Drugs Market

Immunotherapy Drugs Market By Drug Type (Adult Vaccines, Monoclonal Antibodies, Checkpoint Inhibitors, Interleukins, Interferon Alpha & Beta, and Others), By Therapeutic Application (Autoimmune & Inflammatory Diseases, Cancer, Infectious Diseases, and Others), and By End-User (Hospitals, Clinics, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 – 2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-1811 Published Date: Sep-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 106.36 Billion USD 294.94 Billion 12% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Immunotherapy Drugs Market Revenue, 2016 - 2025 (USD Billion)
    • 2.2. Global Immunotherapy Drugs Market: Snapshot
  •  
  • Chapter 3. Immunotherapy Drugs Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Immunotherapy Drugs Market drivers: Impact analysis
      • 3.2.2. Increasing Preference for Targeted Therapy Over Traditional Therapy
      • 3.2.3. Emergence of Biosimilars
    • 3.3. Market Restraints
      • 3.3.1. High Cost of Immunotherapy Treatment
    • 3.4. Opportunities
      • 3.4.1. Emerging Markets
    • 3.5. Porter’s Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Drug Type
      • 3.6.2. Market attractiveness analysis, by Therapeutic Application
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Immunotherapy Drugs Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Immunotherapy Drugs Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapeutic Application Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Immunotherapy Drugs Market - Drug Type Analysis
    • 5.1. Global Immunotherapy Drugs Market: Drug Type overview
      • 5.1.1. Global Immunotherapy Drugs Market revenue share, by Drug Type, 2018 and 2025
    • 5.2. Monoclonal Antibodies
      • 5.2.1. Global Immunotherapy Drugs Market for Monoclonal Antibodies, 2016 - 2025(USD Billion)
    • 5.3. Adult Vaccines
      • 5.3.1. Global Immunotherapy Drugs Market for Adult Vaccines, 2016 - 2025 (USD Billion)
    • 5.4. Checkpoint Inhibitors
      • 5.4.1. Global Immunotherapy Drugs Market for Checkpoint Inhibitors, 2016 - 2025 (USD Billion)
    • 5.5. Interferons Alpha & Beta
      • 5.5.1. Global Immunotherapy Drugs Market for Interferons Alpha & Beta, 2016 - 2025 (USD Billion)
    • 5.6. Interleukins
      • 5.6.1. Global Immunotherapy Drugs Market for Interleukins, 2016 - 2025 (USD Billion)
    • 5.7. Others
      • 5.7.1. Global Immunotherapy Drugs Market for Others, 2016 - 2025 (USD Billion)
  •  
  • Chapter 6. Global Immunotherapy Drugs Market - Therapeutic Application Analysis
    • 6.1. Global Immunotherapy Drugs Market: Therapeutic Application overview
      • 6.1.1. Global Immunotherapy Drugs Market revenue share, by Therapeutic Application, 2018 and 2025
    • 6.2. Cancer
      • 6.2.1. Global Immunotherapy Drugs Market for Cancer, 2016 - 2025 (USD Billion)
    • 6.3. Autoimmune and Inflammatory Diseases
      • 6.3.1. Global Immunotherapy Drugs Market for Autoimmune and Inflammatory Diseases, 2016 - 2025(USD Billion)
    • 6.4. Infectious Diseases
      • 6.4.1. Global Immunotherapy Drugs Market for Infectious Diseases, 2016 - 2025 (USD Billion)
    • 6.5. Others
      • 6.5.1. Global Immunotherapy Drugs Market for Others, 2016 - 2025 (USD Billion)
  •  
  • Chapter 7. Global Immunotherapy Drugs Market - End-User Analysis
    • 7.1. Global Immunotherapy Drugs Market: End-User overview
      • 7.1.1. Global Immunotherapy Drugs Market revenue share, by End-User, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global Immunotherapy Drugs Market for Hospitals, 2016 - 2025(USD Billion)
    • 7.3. Clinics
      • 7.3.1. Global Immunotherapy Drugs Market for Clinics, 2016 - 2025(USD Billion)
    • 7.4. Others
      • 7.4.1. Global Immunotherapy Drugs Market for Others, 2016 - 2025(USD Billion)
  •  
  • Chapter 8. Global Immunotherapy Drugs Market - Regional Analysis
    • 8.1. Global Immunotherapy Drugs Market: Regional overview
      • 8.1.1. Global Immunotherapy Drugs Market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
      • 8.2.2. North America Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
      • 8.2.3. North America Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
        • 8.2.4.2. The U.S. Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
        • 8.2.4.3. The U.S. Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
        • 8.2.5.2. Rest of North America Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
        • 8.2.5.3. Rest of North America Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
      • 8.3.2. Europe Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
      • 8.3.3. Europe Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
        • 8.3.4.2. Germany Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
        • 8.3.4.3. Germany Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
        • 8.3.5.2. UK Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
        • 8.3.5.3. UK Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
        • 8.3.6.2. France Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
        • 8.3.6.3. France Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.3.7.2. Rest of Europe Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.3.7.3. Rest of Europe Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pa
      • cific Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
      • 8.4.2. Asia Pacific Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
      • 8.4.3. Asia Pacific Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.4.4.2. China Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.4.4.3. China Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.4.5.2. Japan Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.4.5.3. Japan Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.4.6.2. India Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.4.6.3. India Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
      • 8.5.2. Latin America Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
      • 8.5.3. Latin America Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.5.4.2. Brazil Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.5.4.3. Brazil Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025 (USD Billion)
        • 8.5.5.2. Rest of Latin America Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025 (USD Billion)
        • 8.5.5.3. Rest of Latin America Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Immunotherapy Drugs Market Revenue, by Drug Type, 2016 - 2025(USD Billion)
      • 8.6.2. The Middle East and Africa Immunotherapy Drugs Market revenue, by Therapeutic Application, 2016 - 2025(USD Billion)
      • 8.6.3. The Middle East and Africa Immunotherapy Drugs Market revenue, by End-User, 2016 - 2025(USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. F. Hoffmann-La Roche AG
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. GlaxoSmithKline
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. AbbVie, Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Amgen, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Merck & Co., Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Bristol-Myers Squibb
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Novartis International AG
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Eli Lilly and Company
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Johnson & Johnson
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. AstraZeneca Plc
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

Table Of Figures

List of Figures

1. Market research application
2. Market research methodology
3. Global Immunotherapy Drugs Market revenue, 2016 – 2025(USD Billion) 
4. Porter’s Five Forces analysis
5. Immunotherapy Drugs Market attractiveness analysis, by Drug Type
6. Immunotherapy Drugs Market attractiveness analysis, by Therapeutic Application
7. Immunotherapy Drugs Market attractiveness analysis, by End-User
8. Immunotherapy Drugs Market attractiveness analysis, by Region
9. Company market share analysis, 2018
10. Global Immunotherapy Drugs Market revenue share by Drug Type, 2018 and 2025
11. Global Immunotherapy Drugs Market for Monoclonal Antibodies, 2016 – 2025 (USD Billion)
12. Global Immunotherapy Drugs Market for Adult Vaccines, 2016 – 2025 (USD Billion)
13. Global Immunotherapy Drugs Market for Checkpoint Inhibitors, 2016 – 2025 (USD Billion)
14. Global Immunotherapy Drugs Market for Interferons Alpha & Beta, 2016 – 2025 (USD Billion)
15. Global Immunotherapy Drugs Market for Interleukins, 2016 – 2025 (USD Billion)
16. Global Immunotherapy Drugs Market for Others, 2016 – 2025 (USD Billion)
17. Global Immunotherapy Drugs Market revenue share by Therapeutic Application, 2018 and 2025
18. Global Immunotherapy Drugs Market for Cancer, 2016 – 2025(USD Billion)
19. Global Immunotherapy Drugs Market for Autoimmune and Inflammatory Diseases, 2016 – 2025(USD Billion)
20. Global Immunotherapy Drugs Market for Infectious Diseases, 2016 – 2025 (USD Billion)
21. Global Immunotherapy Drugs Market for Others, 2016 – 2025 (USD Billion)
22. Global Immunotherapy Drugs Market revenue share by End-User, 2018 and 2025
23. Global Immunotherapy Drugs Market for Hospitals, 2016 – 2025(USD Billion)
24. Global Immunotherapy Drugs Market for Clinics, 2016 – 2025(USD Billion)
25. Global Immunotherapy Drugs Market for Others, 2016 – 2025(USD Billion)
26. North America Immunotherapy Drugs Market Revenue, 2016 – 2025 (USD Billion)
27. Europe Immunotherapy Drugs Market Revenue, 2016 – 2025 (USD Billion)
28. Asia Pacific Immunotherapy Drugs Market Revenue, 2016 – 2025 (USD Billion)
29. Latin America Immunotherapy Drugs Market Revenue, 2016 – 2025 (USD Billion)
30. The Middle East and Africa Immunotherapy Drugs Market Revenue, 2016 – 2025 (USD Billion)


Table Of Tables

List of Tables

1. Immunotherapy Drugs Market: Market Snapshot                                                                                                                        
2. Drivers of Global Immunotherapy Drugs Market: Impact analysis 
3. Restraints of Global Immunotherapy Drugs Market: Impact analysis  
4. North America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025(USD Billion)
5. North America Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
6. North America Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025(USD Billion)
7. North America Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
8. North America Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025(USD Billion)
9. The U.S. Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
10. The U.S. Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
11. The U.S. Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
12. The U.S. Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
13. The U.S. Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
14. Rest of North America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
15. Rest of North America Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
16. Rest of North America Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
17. Rest of North America Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
18. Rest of North America Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
19. Europe Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
20. Europe Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
21. Europe Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
22. Europe Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
23. Europe Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
24. Germany Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
25. Germany Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
26. Germany Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
27. Germany Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
28. Germany Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
29. UK Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
30. UK Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
31. UK Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
32. UK Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
33. UK Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
34. France Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
35. France Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
36. France Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
37. France Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
38. France Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
39. Rest of Europe Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
40. Rest of Europe Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
41. Rest of Europe Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
42. Rest of Europe Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
43. Rest of Europe Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
44. Asia Pacific Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
45. Asia Pacific Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
46. Asia Pacific Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
47. Asia Pacific Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
48. Asia Pacific Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
49. China Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
50. China Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
51. China Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
52. China Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
53. China Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
54. Japan Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
55. Japan Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
56. Japan Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
57. Japan Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
58. Japan Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
59. India Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
60. India Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
61. India Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
62. India Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
63. India Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
64. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
65. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
66. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
67. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
68. Rest of Asia Pacific Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
69. Latin America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
70. Latin America Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
71. Latin America Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
72. Latin America Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
73. Latin America Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
74. Brazil Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
75. Brazil Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
76. Brazil Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
77. Brazil Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
78. Brazil Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
79. Rest of Latin America Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
80. Rest of Latin America Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
81. Rest of Latin America Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
82. Rest of Latin America Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
83. Rest of Latin America Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)
84. The Middle East and Africa Immunotherapy Drugs Market Revenue, by Drug Type, 2016 – 2025 (USD Billion)
85. The Middle East and Africa Immunotherapy Drugs Market Revenue, by Adult Vaccines, 2016 – 2025 (USD Billion)
86. The Middle East and Africa Immunotherapy Drugs Market Revenue, by Therapeutic Application, 2016 – 2025 (USD Billion)
87. The Middle East and Africa Immunotherapy Drugs Market Revenue, by Cancer, 2016 – 2025 (USD Billion)
88. The Middle East and Africa Immunotherapy Drugs Market Revenue, by End-User, 2016 – 2025 (USD Billion)

Methodology

FrequentlyAsked Questions

A group of treatments known as immunotherapy medications are intended to improve or regenerate the body's immune system's capacity to identify and combat cancer or other diseases. In contrast to conventional therapies that directly target the tumour or pathogen, immunotherapy medications function by enhancing the immune system's ability to identify and eliminate abnormal cells.

The development of new and more effective immunotherapy drugs is being driven by ongoing research and technological advancements. Market growth is facilitated by advancements in personalised therapies, immune response enhancement, and the targeting of specific cancer cells.

The global immunotherapy drugs market size was worth around USD 106.36 billion in 2023 and is predicted to grow to around USD 294.94 billion by 2032.

The global immunotherapy drugs market a compound annual growth rate (CAGR) of roughly 12% between 2024 and 2032.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S. Canada, Germany, France, the UK, China, Japan, India, and Brazil.

Some key players of the immunotherapy drugs market include F. Hoffmann-La Roche AG, Amgen, Inc., Novartis International AG, AbbVie, Inc., Merck & Co., Inc., GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc, and Johnson & Johnson, among others.

Choose License Type

  • zion payment modes

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed